Foresite Capital Management VI LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
-76,215
(-11.9%)
New positions
4
Sold out positions
5
Turnover %
27.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Korsana Biosciences, Inc. | 45,813 | NEW |
| Latigo Biotherapeutics, Inc. | 36,803 | NEW |
| VSTM | 13,310 | 110.7% |
| Obsidian Therapeutics, Inc. | 12,578 | NEW |
| Parabilis Medicines, Inc. | 4,915 | 18.0% |
| ZURA | 4,654 | 175.3% |
| IRON | 4,411 | 6212.7% |
| AVBP | 4,379 | 41.8% |
| ENTXW | 3,566 | NEW |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|